DexCom (DXCM) PT Lowered to $92 at Oppenheimer Following 2Q
Tweet Send to a Friend
Oppenheimer lowered its price target on DexCom (NASDAQ: DXCM) to $92.00 (from $98.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
